Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension

Clinical trial NCT03528902 · COMPLETED

Trial details

NCT number: NCT03528902
Sponsor: Vanderbilt University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypertension Pulmonary Arterial Hypertension Familial Primary Pulmonary Hypertension Primary Pulmonary Hypertension Lung Diseases Tamoxifen Estrogen Receptor Antagonist Hormone Antagonists Estrogens

Start date: 2018-10-01
Primary completion: 2023-06-14
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.